niacinamide has been researched along with Leukemia, Myelomonocytic, Acute in 2 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Leukemia, Myelomonocytic, Acute: A pediatric acute myeloid leukemia involving both myeloid and monocytoid precursors. At least 20% of non-erythroid cells are of monocytic origin.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shen, M | 1 |
| Yen, A | 1 |
| Kraljacic, BC | 1 |
| Arguello, M | 1 |
| Amri, A | 1 |
| Cormack, G | 1 |
| Borden, K | 1 |
2 other studies available for niacinamide and Leukemia, Myelomonocytic, Acute
| Article | Year |
|---|---|
Nicotinamide cooperates with retinoic acid and 1,25-dihydroxyvitamin D(3) to regulate cell differentiation and cell cycle arrest of human myeloblastic leukemia cells.
Topics: ADP-ribosyl Cyclase 1; Calcitriol; CD11b Antigen; Cell Cycle; Cell Differentiation; Drug Synergism; | 2009 |
Inhibition of eIF4E with ribavirin cooperates with common chemotherapies in primary acute myeloid leukemia specimens.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Binding, Competitive; Clini | 2011 |